Drug firm, Nectar Lifesciences, on Friday posted an increase of 7.18 per cent in net profit to Rs 32.38 crore for the third quarter ended December 31.
The company had posted a net profit of Rs 30.21 crore for the October—December quarter of 2010.
Net sales of the company stood at Rs 409.92 crore during the quarter against Rs 320.43 crore for the same period last fiscal, Nectar Lifesciences said in a filing to BSE.
Shares of Nectar Lifesciences today closed at Rs 25.05 on BSE, up steep 9.15 per cent from the previous close.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.